RecruitingPhase 3NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Sponsor: AstraZeneca
Minneapolis, MN · +79 more sites
5 recruiting copd studies with a site in Minneapolis, MN.
Sponsor: AstraZeneca
Minneapolis, MN · +79 more sites
Sponsor: Seattle Institute for Biomedical and Clinical Research
Minneapolis, MN · +4 more sites
Sponsor: Helio Genomics
Coon Rapids, MN · Fridley, MN · Minneapolis, MN · +4 more sites
Sponsor: Masonic Cancer Center, University of Minnesota
Minneapolis, MN
Sponsor: Temple University
Minneapolis, MN · +24 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.